1 de outubro de 2020

Mania following use of ibogaine: A case series

17 de abril de 20153min
  1. Cole J. Marta MD1,*,
  2. Wesley C. Ryan MD2,
  3. Alex Kopelowicz MD3 and
  4. Ralph J. Koek MD1

Article first published online: 14 APR 2015

DOI: 10.1111/ajad.12209

http://onlinelibrary.wiley.com/doi/10.1111/ajad.12209/abstract

Background

Ibogaine is a naturally occurring hallucinogen with postulated anti-addictive qualities. While illegal domestically, a growing number of individuals have sought it out for treatment of opiate dependence, primarily in poorly regulated overseas clinics. Existing serious adverse events include cardiac and vestibular toxicity, though ours is the first report of mania stemming from its use.

Objectives

To report on a case series of psychiatric emergency room patients whose unregulated use of ibogaine resulted in mania in three patients with no prior diagnosis of bipolar illness.

Methods

Review and summarize charts of three cases. Relevant literature was also reviewed for discussion.

Results

Two cases of reported ibogaine ingestion for self-treatment of addictions, and one for psycho-spiritual experimentation resulted in symptoms consistent with mania. No prior reports of mania were found in the literature, and the literature suggests growing popularity of ibogaine’s use.

Conclusions

The three cases presented demonstrate a temporal association between ibogaine ingestion and subsequent development of mania.

Scientific Significance

In light of these cases, clinicians faced with a new onset mania may benefit from careful substance use and treatment history, specifically regarding opiates. In the vulnerable and often desperate addiction population, in particular, the number of patients seeking this treatment appears to be growing. We advise clinicians to be prepared for discussing the safety, efficacy, and paucity of good data regarding ibogaine with patients who may be considering its use.


Sobre a UNIAD

A Unidade de Pesquisa em álcool e Drogas (UNIAD) foi fundada em 1994 pelo Prof. Dr. Ronaldo Laranjeira e John Dunn, recém-chegados da Inglaterra. A criação contou, na época, com o apoio do Departamento de Psiquiatria da UNIFESP. Inicialmente (1994-1996) funcionou dentro do Complexo Hospital São Paulo, com o objetivo de atender funcionários dependentes.



Newsletter